Latest Health News

Audeara Limited reports a strong start to FY26 with a 46% revenue increase driven by Australian wholesale growth and a key international partnership. The company’s global ambitions are further highlighted by multiple export award nominations.

Lendlease Corporation has released its full year financial results for 2025, accompanied by the detailed Final Report. Investors await insights beyond the headline announcement to gauge the company’s trajectory.

BlueScope Steel’s FY2025 results reveal a dip in revenue and earnings amid challenging market conditions, yet the company maintains robust cash flow and advances its sustainability agenda.

Bluescope Steel Limited has announced a final dividend of 30 cents per share, 50% franked, payable in October 2025. This dividend reflects the company’s steady financial position for the year ending June 2025.

Contact Energy Limited has announced a total dividend of NZD 0.2529 per share for the six months ending June 2025, including an ordinary and supplementary dividend, with a Dividend Reinvestment Plan available.

The a2 Milk Company delivered record FY25 results with $1.9 billion in sales and announced a transformative acquisition of a New Zealand manufacturing facility, alongside divesting its stake in Mataura Valley Milk and planning a $300 million special dividend.

The a2 Milk Company reported a robust 13.5% revenue increase and a 21.1% rise in net profit for the fiscal year ending June 2025, alongside healthy dividend declarations.

NGE Capital Limited reported a steady half-year profit increase alongside a notable rise in net tangible assets per share, continuing its share buy-back program and initiating new investments.

MC Mining has officially begun open pit mining at its flagship Makhado hard coking coal project in South Africa, advancing steadily towards full production by year-end 2025.

WAM Leaders Limited reported a strong $63.8 million net profit for FY2025 and declared a fully franked final dividend of 4.7 cents per share, despite its investment portfolio underperforming the benchmark index.

EMVision Medical Devices has been awarded a $3 million non-dilutive government grant to conduct a pioneering clinical study using its telehealth-enabled emu™ brain scanner in regional South Australia, aiming to transform stroke diagnosis and treatment.

McPherson’s Limited has finalized a key pharmacy wholesaler agreement with API Services Australia, marking the completion of its new distribution model and transitioning significant revenue previously handled direct-to-store.